cyclo(glycylprolyl)
RN given refers to cpd without isomeric designation
Also Known As:
cyclo(Gly-O-Pro); cyclo(Gly-Pro); cyclo(glycyl-L-prolyl); cyclo(glycylprolyl), (L)-isomer; Pyrrolo(1,2-a)pyrazine-1,4-dione, hexahydro-, (S)-
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Barreto, Emiliano:
1 article
(12/2015)
|
| 2. | Diaz, Bruno Lourenço:
1 article
(12/2015)
|
| 3. | Ferro, Jamylle Nunes de Souza:
1 article
(12/2015)
|
| 4. | Lucca-Júnior, Waldecy:
1 article
(12/2015)
|
| 5. | Quintans, Jullyana de Souza Siqueira:
1 article
(12/2015)
|
| 6. | Quintans-Júnior, Lucindo José:
1 article
(12/2015)
|
| 7. | de Aquino, Fernanda Lima Torres:
1 article
(12/2015)
|
| 8. | de Araújo, Almair Ferreira:
1 article
(12/2015)
|
| 9. | de Brito, Renan Guedes:
1 article
(12/2015)
|
| 10. | de Souza, Lucas Costa:
1 article
(12/2015)
|
Related Diseases
| 1. | Reperfusion Injury
01/01/2023
- " In addition, there were 75 differentially expressed exosomal proteins between RIPC participants and controls, which involved the regulation of insulin-like growth factor (IGF) transport, neutrophil degranulation, vesicle-mediated transport, etc. Furthermore, we found differentially expressed theobromine, cyclo gly-pro, hemopexin (HPX), and apolipoprotein A1 (ApoA1), which are associated with neuroprotective benefits in ischemia/reperfusion injury. "
|
| 2. | Inflammation (Inflammations)
|
|
Related Drugs and Biologics